1. A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03). Issue 1 (February 2023) Authors: Procopio, Giuseppe; Claps, Mélanie; Pircher, Chiara; Porcu, Luca; Sepe, Pierangela; Guadalupi, Valentina; De Giorgi, Ugo; Bimbatti, Davide; Nolè, Franco; Carrozza, Francesco; Buti, Sebastiano; Iacovelli, Roberto; Ciccarese, Chiara; Masini, Cristina; Baldessari, Cinzia; Doni, Laura; Cusmai, Antoni... Journal: Tumori Issue: Volume 109:Issue 1(2023) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies. (September 2017) Authors: Ciccarese, Chiara; Iacovelli, Roberto; Brunelli, Matteo; Massari, Francesco; Bimbatti, Davide; Fantinel, Emanuela; De Marco, Vincenzo; Porcaro, Antonio Benito; Martignoni, Guido; Artibani, Walter; Tortora, Giampaolo Journal: European journal of cancer Issue: Volume 83(2017) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). Issue 1 (2nd January 2022) Authors: Mennitto, Alessia; Zattarin, Emma; Di Maio, Massimo; Bimbatti, Davide; De Giorgi, Ugo; Buti, Sebastiano; Santini, Daniele; Casadei, Chiara; Sorarù, Mariella; Messina, Carlo; Mucciarini, Claudia; Di Lorenzo, Giuseppe; Roviello, Giandomenico; Buttigliero, Consuelo; Stellato, Marco; Sepe, Pierangela... Journal: Expert review of anticancer therapy Issue: Volume 22:Issue 1(2022) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients. Issue 6 (31st March 2019) Authors: Iacovelli, Roberto; Ciccarese, Chiara; Fornarini, Giuseppe; Massari, Francesco; Bimbatti, Davide; Mosillo, Claudia; Rebuzzi, Sara Elena; Di Nunno, Vincenzo; Grassi, Massimiliano; Fantinel, Emanuela; Ardizzoni, Andrea; Tortora, Giampaolo Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 6(2019) Page Start: 1283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma. Issue 4 (April 2015) Authors: Massari, Francesco; Ciccarese, Chiara; Bimbatti, Davide; Fantinel, Emanuela; Modena, Alessandra; Simbolo, Michele; Brunelli, Matteo; Artibani, Walter; Martignoni, Guido; Scarpa, Aldo; Tortora, Giampaolo Journal: Anti-cancer drugs Issue: Volume 26:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy. Issue 4 (April 2015) Authors: Massari, Francesco; Ciccarese, Chiara; Bimbatti, Davide; Fantinel, Emanuela; Modena, Alessandra; Simbolo, Michele; Brunelli, Matteo; Artibani, Walter; Martignoni, Guido; Scarpa, Aldo; Tortora, Giampaolo Journal: Anti-cancer drugs Issue: Volume 26:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comprehensive geriatric assessment is an independent prognostic factor in older patients with metastatic renal cell cancer treated with first-line Sunitinib or Pazopanib: a single center experience. Issue 2 (March 2021) Authors: Pierantoni, Francesco; Basso, Umberto; Maruzzo, Marco; Lamberti, Evelina; Bimbatti, Davide; Tierno, Giuseppina; Bergo, Eleonora; Brunello, Antonella; Zagonel, Vittorina Journal: Journal of geriatric oncology Issue: Volume 12:Issue 2(2021) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. De novo metastatic castration sensitive prostate cancer: State of art and future perspectives. (November 2018) Authors: Mosillo, Claudia; Iacovelli, Roberto; Ciccarese, Chiara; Fantinel, Emanuela; Bimbatti, Davide; Brunelli, Matteo; Bisogno, Iolanda; Kinspergher, Stefania; Buttigliero, Consuelo; Tucci, Marcello; Caffo, Orazio; Tortora, Giampaolo Journal: Cancer treatment reviews Issue: Volume 70(2018) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study. (20th March 2022) Authors: Roviello, Giandomenico; Gambale, Elisabetta; Giorgione, Roberta; Santini, Daniele; Stellato, Marco; Fornarini, Giuseppe; Rebuzzi, Sara Elena; Basso, Umberto; Bimbatti, Davide; Doni, Laura; Nesi, Gabriella; Bersanelli, Melissa; Buti, Sebastiano; De Giorgi, Ugo; Galli, Luca; Sbrana, Andrea; Conca, ... Journal: Cancer medicine Issue: Volume 11:Number 16(2022) Page Start: 3084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Fatal hyperprogression induced by nivolumab in metastatic renal cell carcinoma with sarcomatoid features: a case report. Issue 2 (27th August 2020) Authors: Dionese, Michele; Pierantoni, Francesco; Maruzzo, Marco; Bimbatti, Davide; Deppieri, Filippo M.; Maran, Michela; Gardiman, Marina P.; Basso, Umberto Journal: Anti-cancer drugs Issue: Volume 32:Issue 2(2021) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗